Analysts Set Solid Biosciences Inc. (NASDAQ:SLDB) Target Price at $17.50

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given an average recommendation of “Buy” by the six ratings firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the […]

Leave a Reply

Your email address will not be published.

Previous post Q2 2024 Earnings Forecast for Ayr Wellness Inc. Issued By Roth Capital (OTCMKTS:AYRWF)
Next post TransDigm Group (NYSE:TDG) Upgraded to Buy at StockNews.com